Cephalon's Amrix IP Invalid, Infringed: Judge
By Roxanne Palmer · May 12, 2011, 9:19 PM EDT
The Delaware federal judge overseeing multidistrict litigation over Cephalon Inc.'s Amrix drug ruled Tuesday that Mylan Pharmaceuticals Inc. and Barr Laboratories Inc. infringed two patents covering the muscle relaxant, but also...
To view the full article, register now.